Malformacje jamiste
Etiologia i przyczyny

Malformacje jamiste (cavernous malformations) to patologiczne skupiska cienkościennych naczyń krwionośnych z poszerzonym światłem, wypełnione krwią lub skrzepami, lokalizujące się głównie w mózgu i rdzeniu kręgowym. Występują sporadycznie (80% przypadków) lub rodzinnie (20%), z dziedziczeniem autosomalnym dominującym i niepełną penetracją. Mutacje w genach KRIT1 (CCM1, 7q21.2), CCM2 (7p13) i PDCD10 (CCM3, 3q26.1) odpowiadają za 85-95% rodzinnych przypadków, prowadząc do zaburzeń integralności połączeń śródbłonkowych i zwiększonej przepuszczalności naczyń. Patogeneza opiera się na mechanizmie „dwóch uderzeń”: mutacji germinalnej i somatycznej, co skutkuje całkowitą utratą funkcji genu w komórkach naczyń. Forma rodzinna cechuje się wieloogniskowością, wyższym ryzykiem krwawienia (~1% rocznie) i wcześniejszym początkiem objawów, zwłaszcza przy mutacji CCM3, podczas gdy forma sporadyczna zwykle manifestuje się pojedynczą zmianą i niższym ryzykiem krwawienia (0,1-0,6% rocznie). W populacji Latynosów meksykańskiego pochodzenia odsetek rodzinnych przypadków może sięgać 50% z powodu mutacji Q455X w KRIT1.

Etiologia malformacji jamistych

Malformacje jamiste (ang. cavernous malformations, cavernous angiomas, cavernomas) to nieprawidłowe skupiska naczyń krwionośnych o cienkich ścianach, które mogą występować w mózgu, rdzeniu kręgowym lub innych częściach ciała. Charakteryzują się nieprawidłowo poszerzonym światłem naczyń, tworzącym jamy wypełnione wolno płynącą krwią lub skrzepami12. Malformacje jamiste przypominają wyglądem malinę lub morwę, a ich ściany są cieńsze i słabsze niż w przypadku normalnych naczyń krwionośnych34.

Dokładna przyczyna powstawania malformacji jamistych nie jest w pełni poznana. Uważa się, że mogą one powstawać przed lub wkrótce po urodzeniu, choć mogą się również rozwijać w późniejszym okresie życia56. Około 0,3-0,5% populacji ogólnej ma malformacje jamiste, a największa częstość występowania objawowych zmian przypada na wiek 30-50 lat7.

Formy malformacji jamistych

Wyróżnia się dwie główne formy malformacji jamistych: sporadyczną i rodzinną (dziedziczną)89.

  • Forma sporadyczna – występuje w około 80% przypadków, charakteryzuje się obecnością pojedynczej zmiany bez obciążenia rodzinnego1011. Pacjenci z tą formą zwykle mają mniej objawów lub są bezobjawowi12.
  • Forma rodzinna (dziedziczna) – stanowi około 20% przypadków (w niektórych badaniach szacuje się na 10-30%), charakteryzuje się występowaniem wielu zmian u jednego pacjenta oraz obciążeniem rodzinnym113. U pacjentów z tą formą istnieje 50% ryzyko przekazania genu zmutowanego potomstwu14.

Warto zaznaczyć, że w populacji Latynosów pochodzenia meksykańskiego odsetek przypadków rodzinnych może sięgać nawet 50%, co wiąże się z obecnością specyficznej mutacji założycielskiej Q455X w genie KRIT11516.

Podłoże genetyczne malformacji jamistych

Badania genetyczne zidentyfikowały trzy główne geny, których mutacje są odpowiedzialne za powstawanie rodzinnych malformacji jamistych18:

  • KRIT1 (CCM1) – zlokalizowany na chromosomie 7q21.2
  • CCM2 (MGC4607) – zlokalizowany na chromosomie 7p13
  • PDCD10 (CCM3) – zlokalizowany na chromosomie 3q26.1

Mutacje w tych trzech genach odpowiadają za 85-95% wszystkich przypadków rodzinnych malformacji jamistych17. Rozkład częstości mutacji wśród pacjentów z rodzinną formą malformacji jamistych wskazuje, że mutacje w genach CCM1 i CCM2 są najczęstsze (łącznie 70-80% przypadków), podczas gdy mutacje w genie CCM3 stanowią około 15% przypadków18.

Białka kodowane przez te geny odgrywają kluczową rolę w tworzeniu połączeń międzykomórkowych (junction) pomiędzy komórkami śródbłonka naczyniowego oraz oddziaływują z białkami cytoszkieletu podczas angiogenezy1920. Mutacje prowadzące do utraty funkcji tych genów powodują osłabienie połączeń międzykomórkowych i zwiększenie przepuszczalności ścian naczyń, co skutkuje tworzeniem się nieprawidłowych struktur naczyniowych21.

Hipoteza „dwóch uderzeń” w patogenezie malformacji jamistych

Coraz więcej dowodów naukowych wskazuje na mechanizm „dwóch uderzeń” (two-hit mechanism) jako kluczowy w patogenezie malformacji jamistych1922. Zgodnie z tą hipotezą:

  • W przypadku formy rodzinnej – pierwszy „cios” to mutacja germinalna (odziedziczona), obecna we wszystkich komórkach organizmu, która inaktywuje jedną kopię genu CCM. Drugi „cios” to somatyczna mutacja w drugiej kopii tego samego genu, która występuje tylko w komórkach naczyń krwionośnych mózgu, prowadząc do całkowitej utraty funkcji genu i rozpoczęcia formowania się malformacji jamistej23.
  • W przypadku formy sporadycznej – oba „ciosy” są mutacjami somatycznymi nabytymi w tych samych genach CCM, ale występują tylko w komórkach naczyń krwionośnych tworzących zmianę2324.

Badania przeprowadzone na usuniętych chirurgicznie zmianach sporadycznych wykazały obecność somatycznych mutacji w tych samych trzech genach CCM, co sugeruje identyczne mechanizmy molekularne w obu formach malformacji jamistych24. Istnieją również dowody na możliwość mechanizmu trans-heterozygotyczności, w którym pacjent ma synergistyczne mutacje w różnych genach szlaku CCM (np. mutację germinalną w genie KRIT1 z dodatkową mutacją somatyczną w genie CCM2 lub PDCD10), co może wyjaśniać zmienność kliniczną wewnątrz rodzin25.

Czynniki ryzyka i czynniki wpływające na rozwój malformacji jamistych

Oprócz czynników genetycznych, zidentyfikowano kilka innych czynników, które mogą wpływać na rozwój malformacji jamistych lub ujawnienie się ich objawów26:

  • Radioterapia – ekspozycja na promieniowanie, szczególnie radioterapia mózgu lub rdzenia kręgowego, może prowadzić do powstania malformacji jamistych w okresie od 2 do 20 lat po leczeniu127. Stanowi to około 9% przypadków malformacji jamistych w populacji pediatrycznej15.
  • Anomalie rozwojowe żylne (DVA) – około 40% sporadycznych malformacji jamistych rozwija się w bezpośrednim sąsiedztwie anomalii rozwojowych żylnych, co może sugerować różnicę w mechanizmach rozwojowych między sporadycznymi a rodzinnymi malformacjami jamistymi1028.
  • Zmiany hormonalne – niektóre badania sugerują, że zmiany hormonalne, takie jak te występujące podczas ciąży, mogą nasilać objawy lub prowadzić do wykrycia wcześniej bezobjawowej malformacji jamistej29.
  • Urazy głowy – chociaż rzadko, urazy głowy mogą być potencjalnym czynnikiem wywołującym krwawienie z istniejącej malformacji jamistej lub, według niektórych sugestii, jej powstanie3026.
  • Wiek – wraz z wiekiem ryzyko wystąpienia objawów lub krwawienia z malformacji jamistej może wzrastać, prawdopodobnie z powodu skumulowanych efektów małych, niewykrytych epizodów krwawienia29.

Różnice między formą rodzinną a sporadyczną

Forma rodzinna i sporadyczna malformacji jamistych wykazują istotne różnice kliniczne3132:

Cecha Forma rodzinna Forma sporadyczna
Liczba zmian Wieloogniskowa (często 5 lub więcej) Zazwyczaj pojedyncza
Dziedziczenie Autosomalnie dominujące Brak
Penetracja Niepełna Nie dotyczy
Częstość występowania 10-30% przypadków 70-90% przypadków
Ryzyko krwawienia Wyższe (około 1% rocznie) Niższe (0,1-0,6% rocznie dla zmian bezobjawowych)
Współwystępowanie z DVA Rzadziej Częściej (do 40% przypadków)

Dodatkowo, pacjenci z mutacją w genie CCM3 mają zwykle wcześniejszy początek objawów (często przed 10. rokiem życia), częstsze krwawienia i szybsze powstawanie nowych zmian (2-3 nowe zmiany rocznie, w porównaniu do średnio jednej zmiany co dwa lata dla pacjentów z mutacjami CCM1 lub CCM2)3318.

Patofizjologia malformacji jamistych

Na poziomie komórkowym i molekularnym, patofizjologia malformacji jamistych wiąże się z wieloma mechanizmami2434:

  • Zaburzenie integralności połączeń międzykomórkowych – najważniejszą dysfunkcją zidentyfikowaną w mutacjach CCM jest zwiększona przepuszczalność połączeń śródbłonka, efekt mediowany przez aktywność Notch1 i kinazy Rho. Koreluje to z charakterystycznym obrazem histopatologicznym malformacji jamistych, w którym brakuje dojrzałej architektury ściany naczynia i dojrzałej bariery krew-mózg24.
  • Wzmożona aktywność angiogenna – obecność związków wskazujących na wzmożoną aktywność angiogenną w obrębie malformacji jamistych34.
  • Progresywny proces zakrzepicy – postuluje się, że progresywny proces zakrzepicy w żyłkach mózgowych związany z krwawieniem z kapilar i ekspansją krwiaka może być potencjalnym mechanizmem patofizjologicznym rozwoju malformacji jamistych34.
  • Rola układu żylnego – rola układu żylnego była badana jako możliwy czynnik w rozwoju zmian34.
  • Mikrobiom i odpowiedź immunologiczna – najnowsze badania sugerują niespodziewaną rolę mikrobiomu i sygnalizacji odporności wrodzonej w patogenezie tej choroby naczyniowej mózgu22.
  • Polimorfizmy pojedynczych nukleotydów (SNP) – polimorfizmy genów odpowiedzi zapalnej i immunologicznej zostały powiązane z różnymi cechami naturalnej historii malformacji jamistych, w tym obciążeniem chorobą i ciężkością ryzyka krwotoku śródmózgowego35.

Charakterystyka histopatologiczna

Histologicznie malformacje jamiste składają się z „podobnych do morwy” skupisk poszerzonych, zhialinizowanych, cienkościennych naczyń włosowatych, otoczonych złogami hemosyderyny. Naczynia te są w różnym stopniu wypełnione skrzepami. W przeciwieństwie do teleangioektazji kapilarnych ośrodkowego układu nerwowego, nie ma prawidłowej tkanki mózgowej między przestrzeniami tych zmian36. Brak pośredniej tkanki mózgowej jest jednym z charakterystycznych markerów patologicznych malformacji jamistych34.

Podsumowanie etiologii malformacji jamistych

Malformacje jamiste to złożone zmiany naczyniowe, których etiologia obejmuje czynniki genetyczne, somatyczne mutacje i potencjalne czynniki środowiskowe. Chociaż znaczna część przypadków jest sporadyczna, około 20% wykazuje dziedziczenie autosomalnie dominujące z niepełną penetracją. Zidentyfikowano trzy główne geny (CCM1/KRIT1, CCM2, CCM3/PDCD10) odpowiedzialne za rodzinne malformacje jamiste, a ich mutacje prowadzą do zaburzeń w tworzeniu i utrzymaniu integralności naczyń krwionośnych. Hipoteza „dwóch uderzeń” wydaje się najlepiej wyjaśniać mechanizm powstawania tych zmian, zarówno w formie rodzinnej, jak i sporadycznej. Radioterapia, obecność anomalii rozwojowych żylnych i inne czynniki mogą również odgrywać rolę w powstawaniu malformacji jamistych lub ujawnianiu się ich objawów klinicznych11921.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Cavernous malformations – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/symptoms-causes/syc-20360941
    Cerebral cavernous malformations (CCMs) are groups of tightly packed, irregular small blood vessels with thin walls. […] Most cerebral cavernous malformations (CCMs) are known as the „sporadic form.” They occur as a single malformation without any family history. […] However, about 20% of people with a CCM have a genetic form. This form is passed down in families, known as familial cavernous malformation syndrome. […] To date, research has identified three genetic changes responsible for cavernous malformations passed down through families. […] Familial CCMs are passed down in families through a change in one of these genes: KRIT1, also called CCM1, CCM2, PDCD10, also called CCM3. […] Radiation to the brain or spinal cord also may result in CCMs within 2 to 20 years afterward. Other rare syndromes may be associated with CCM.
  • #2 Cavernous Malformation – 20 Questions Answered
    https://www.alliancetocure.org/home/for-patients/newly-diagnosed/20-questions-answered-cavernous-malformation-angioma-cavernoma/
    There is no typical way in which cavernous malformations (also known as cavernous angioma or cavernoma) affect people. The symptoms, the course of the illness, and its severity can be very different from person to person. […] Cavernous malformations are also known as cavernous angioma, CCM, and cavernoma. They are made of abnormal blood vessels. They are not cancerous. Cavernous malformations are made of the smallest blood vessels, called capillaries. They resemble mulberries and have very thin walls compared with other blood vessels. Blood moves through them very slowly. The thin vessel walls can be leaky, allowing blood into the surrounding brain or spinal cord tissue. We believe about one in every 500 people has a cavernous malformation, but most people never have symptoms. Of the people who have a cavernous malformation, we believe many will never have a symptomatic hemorrhage.
  • #3 Delving Into Cavernous Malformations – Pacific Neuroscience Institute
    https://www.pacificneuroscienceinstitute.org/blog/neurovascular-malformations/delving-into-cavernous-malformations/
    Cavernous malformations (CMs), also known as cavernomas or cavernous angiomas, are clusters of abnormal, dilated blood vessels that can form in the brain, spinal cord, or other parts of the body characterized by distended blood-filled caverns. […] The exact cause of cavernous malformations remains unclear, but they can be categorized into two main types: sporadic and familial. […] Sporadic Cavernous Malformations: These occur randomly and usually present as a single lesion. They are thought to be caused by mutations in the genes involved in blood vessel formation and stability. […] Familial Cavernous Malformations: These are inherited and typically involve multiple lesions. About 20-30% of cases are inherited and caused by mutations in one of three known genes: KRIT1, CCM2, or PDCD10.
  • #4 Cavernous Malformations – Seattle Children’s
    https://www.seattlechildrens.org/conditions/cavernous-malformations/
    Cavernous malformations are tightly packed clusters of tiny blood vessels (capillaries) with walls that are thinner, weaker and less elastic than normal. […] A cavernous malformation may be present at birth (congenital) or form after birth. […] In 10% of people with CCMs, the lesions are caused by gene changes (variants) that can be passed down in families. […] Researchers have found some of the genes that cause familial CCMs. […] In some children, the CCM is caused by gene changes (variants) that can be passed down in families.
  • #5 Cavernous Malformations Causes | Aaron Cohen-Gadol, MD
    https://www.aaroncohen-gadol.com/en/patients/cavernous-malformation/types/causes
    Cavernous malformations are likely to occur before or shortly after birth although they may develop any time during your lifetime. […] There are two types of cavernous malformations: sporadic and familial. Sporadic malformations happen randomly, whereas familial malformations are hereditary and occur as a result of genetic mutations that are passed down from parent to child. […] Both familial and sporadic cavernous malformations are typically the result of a mutation in the CCM1 (KRIT1), CCM2 (MGC4607), and CCM3 (PDCD10) genes. […] Research so far has not found precisely what causes these mutations. […] Cavernous malformations can result from a genetic mutation that causes abnormal development of blood vessels. […] Unfortunately, there is currently no way to prevent cavernous malformations from occurring, but treatment options are available.
  • #6 Cavernous Malformations
    https://www.nm.org/conditions-and-care-areas/neurosciences/cavernous-malformations
    Cavernous malformations probably form before or shortly after birth. […] In approximately 20% of cases, the condition is caused by an inherited gene mutation. […] In other cases, they appear without a family history. […] Currently, cavernous malformations cant be prevented. Researchers hope that by learning more about the genes linked to these growths, prevention could become possible.
  • #7 Cavernous Malformation: Symptoms, Causes & Treatment Options
    https://njbrainspine.com/condition/cavernous-malformation/
    Cavernous malformations occur in 0.3-0.5% of the population and in 1/200 people between the ages of 30-50. […] Pathologically, a cavernoma contains vascular channels without the typical architecture of normal blood vessels. […] Hemorrhage rates range from 0.5% to 6% annually; bleeding rates are higher in brainstem cavernomas or in those that had bled previously. […] Apart from surveillance of asymptomatic lesions, treatment is limited to surgery and is indicated in patients with hemorrhagic lesions, in those with intractable seizures or who have suffered from a neurological disability.
  • #8 Cerebral Cavernous Malformations | National Institute of Neurological Disorders and Stroke
    https://www.ninds.nih.gov/health-information/disorders/cerebral-cavernous-malformations
    Cerebral cavernous malformations (CCMs) are lesions in the brain that can leak blood into the brain and cause symptoms like seizures, headaches, or back pain. […] CCMs can happen on their own (sporadic) or run in families (this is called familial CCM). […] Familial CCMs happen when there is a variation (also called a mutation) in one of three genes: KRIT1 (CCM1), CCM2, or PDCD10 (CCM3). These genes make proteins that create junctions between blood vessels. When genetic variations affect protein production, cell junctions can weaken and cause CCMs to form. […] Familial CCM is inherited in an autosomal dominant pattern. This means a person only needs to inherit one copy of the affected gene from either parent to have the condition.
  • #9 Cavernous hemangioma – Wikipedia
    https://en.wikipedia.org/wiki/Cavernous_hemangioma
    Cavernous hemangioma, also called cavernous angioma, venous malformation, or cavernoma, is a type of venous malformation due to endothelial dysmorphogenesis from a lesion which is present at birth. […] Most cases of cavernomas are thought to be congenital; however they can develop over the course of a lifetime. While there is no definitive cause, research suggests that genetic mutations cause the condition. […] Familial cerebral cavernous malformations are known to occur. The mutations may be inherited in an autosomal dominant fashion or occur sporadically. Overall, familial disease is thought to be responsible for one-third to one-half of cases. […] Several genes K-Rev interaction trapped 1 (1), malcavernin (CCM2) and programmed cell death protein 10 (3) have been identified as having mutations thought to be related to these lesions.
  • #10 Cavernous Malformation – Goodman CampbellHamburger MenuSearch IconSearch IconX IconFacebook IconInstagram IconYoutube IconLinkedIn Icon
    https://www.goodmancampbell.com/conditions/brain/neurovascular/cavernous-malformation/
    About 80% of cavernomas occur randomly (sporadic form). They are often associated with an architecturally distinctive vein (called a venous angioma or developmental venous anomaly). Another 20% of patients have the familial form. Most of these patients have a mutation in one of three genes which can then be passed on to their children. In the familial form, patients often have numerous cavernomas. […] Cavernomas may also develop following radiation therapy to the brain.
  • #11 Cavernoma: Treatment & Care | UVA Health
    https://uvahealth.com/services/cavernoma
    Cavernomas are enlarged and deformed blood vessels gathered into clusters. These clusters, called angiomas, may look bubbly, like raspberries. […] Cavernomas come in two forms: Sporadic most common; when only one cavernoma develops, and the condition doesn’t run in your family. Familial less common; more than one cavernoma occurs and the condition runs in your family. […] Other terms used for this condition includes cerebral cavernous malformations (CCMs), cavernous angiomas, or cavernous hemangiomas.
  • #12 Cavernous Malformations | Symptoms, Diagnosis & Treatment
    https://www.cincinnatichildrens.org/health/c/cavernous-malformation
    Cavernous malformations are also known as cavernous angiomas, cavernous hemangiomas, cerebral cavernous malformations or cavernomas. […] It is a condition in which clusters of blood vessels in your child’s brain or spinal cord form abnormally, creating caverns filled with slow-moving blood. […] Approximately one in four cases of cavernous malformation are inherited. The remaining cases have no clear cause. […] Individuals with inherited cavernous malformations are more likely to have multiple cavernomas in the brain, increasing their risk of developing symptoms. […] Half of the people who inherit cavernous malformations will pass the condition on to their children. […] Non-inherited cases often result in just one cavernoma with few or no symptoms.
  • #13 Cavernous Malformations – AANS
    http://www.aans.org/patients/conditions-treatments/cavernous-malformations/
    Cavernous malformations are clusters of abnormal, tiny blood vessels and larger, stretched-out, thin-walled blood vessels filled with blood and located in the brain. […] It is not known what causes cerebral cavernous malformations. About 20% of people with cerebral cavernous malformations have the familial form, meaning they inherited the condition. Researchers have identified genetic mutations that can cause cerebral cavernous malformations, such as the genes KRIT1 (CCM1), CCM2 and PDCD10 (CCM3).
  • #14 Genetics of Cavernous Malformation – Alliance to Cure Cavernous Malformation
    https://www.alliancetocure.org/home/cavernous-angioma-in-depth/genetics/genetics-of-cavernous-angioma/
    Mutations of Any of Three Genes Can Cause Familial Cavernous Malformations […] Cavernous malformations (also known as cavernous angioma or cavernoma) can occur either sporadically, or they may run in families and be inherited due to a genetic mutation. […] Familial cavernous malformations are caused by a single gene mutation in one of three different genes, CCM1, CCM2, or CCM3. In familial cavernous malformation, it is typical to develop multiple lesions and to have affected family members in consecutive generations. […] Familial cavernous malformations are caused by a hereditary illness that follows an autosomal dominant pattern of inheritance. This means that only one parent must have the illness for it to be passed on to offspring. Each child of a parent with familial cavernous malformation has a 50% chance of inheriting the illness.
  • #15 < ?php wp_title( '|', true, 'right' ); ?>
    https://surgicalneurologyint.com/surgicalint-articles/pediatric-cerebral-cavernous-malformations-genetics-pathogenesis-and-management/
    Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management […] The development of CCMs appears to increase with age, reaching a plateau in late adolescence, as demonstrated by Al-Holou et al. in 2012. […] According to studies by Gross et al. in 2011 and 2015, among children with CCMs, 10% of cases are familial and approximately 17% have multiple lesions. […] Also evident is an apparent racial disparity in etiology, with the familial form accounting for half of the cases in Hispanic patients and only 10-20% of affected Caucasians. […] The overall incidence for the development of new CCMs in children is correlated with their pre-existing cavernoma burden. […] Prior radiation also appears to confer a risk of de novo CCM formation, representing 9% of pediatric CCMs.
  • #16 Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management | European Journal of Human Genetics
    https://www.nature.com/articles/ejhg2011155
    The underlying genetic mechanism in CCM is partially understood. Second-site genetic mutations have been proposed as one of the possible molecular mechanisms. […] The proportion of familial cases has been estimated approximately at 20% in the general population, and estimated to be as high as 50% in Hispanic-American patients of Mexican descent. These families are all apparently related to the same founder mutation (Q455X) in the KRIT1 gene. […] Different explanations have been provided for the molecular pathogenesis of lesion formation in CCM. First, a Knudsonian two-hit mechanism might be involved. According to this mechanism, CCM formation would require a complete loss of the two alleles of a given CCM gene within affected cells. Loss of one of the alleles (first hit) would be the result of a germline mutation, whereas loss of the second allele (or second hit) will occur somatically.
  • #17 Cerebral cavernous malformation: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/cerebral-cavernous-malformation/
    Cerebral cavernous malformations are collections of small blood vessels (capillaries) in the brain that are enlarged and irregular in structure. […] Mutations in at least three genes, KRIT1 (also known as CCM1), CCM2, and PDCD10 (also known as CCM3), cause familial cerebral cavernous malformations. […] Mutations in these three genes account for 85 to 95 percent of all cases of familial cerebral cavernous malformations. […] The cause of this form of the condition is unknown.
  • #18 Azthena logo with the word Azthena
    https://www.news-medical.net/health/What-are-cerebral-cavernous-malformations.aspx
    Cerebral cavernous malformation (CCM), also knows a cavernous hemangioma, cavernous angioma or cavernoma, is a brain blood vessel malformation characterized by irregularly clustered small thin-walled blood vessels. […] Genetic studies with familial cases of CCM have identified mutations is CCM1, CCM2 or CCM3 causes CCM lesions. Mutations in these three genes accounts for about 90% of all familial cases, the cause of the rest 10% arises from other unknown cause. […] Somatic mutations in these three genes have also been identified in sporadic cases of CCM. Among these three genes, mutations in CCM1 and CCM2 gene are more common, together account for 70-80% of familial cases, whereas mutations in CCM3 gene accounts for about 15% of familial cases. […] But Mutations in CCM3 gene cause greater lesion burden and higher risk and early onset of hemorrhage, usually within 10 years old in age. Patients with CCM3 mutations more likely devastated by lesion burden and repeated hemorrhages.
  • #19 Cerebral Cavernous Malformations – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538144/
    Experts do not fully understand the pathogenesis of CCMs, but the genetic underpinnings have been clarified in recent years. CCMs may be sporadic or have a familial cause. Some studies report that up to 20% of cases follow a familial, autosomal dominant inheritance pattern, while others estimate that between 40% and 60% of cases are familial. Sporadic cases tend to present with a single CCM, while familial cases are characterized by multiple CCMs in a single patient. […] Evolving understanding of genetic associations with CCMs has led to identifying 3 homologically distinct genes responsible for CCM development: CCM1/KRIT1, CCM2/Malcavernin, and CCM3/PDCD10 genes located on the 7q, 7p, and 3p chromosomes, respectively. Those expressed genes encoded by the CCM genes interact in neural tissue with capillary endothelial tight junctions and cytoskeletal proteins during angiogenesis. A common deletion in CCM2 was found to be responsible for clustering among Ashkenazi Jews. Many authors have proposed a „2-hit” hypothesis of familial CCM wherein epigenetic or environmental exposure (the second hit) results in CCM gene loss-of-function and may account for the proclivity of these lesions to accumulate over time and with radiation exposure. Studies of sporadic CCM support a common pathway involving de novo mutations of CCM genes.
  • #20 Orphanet: Familial cerebral cavernous malformation
    https://www.orpha.net/en/disease/detail/221061
    A rare, capillary-venous malformations characterized by closely clustered irregular dilated capillaries that can be asymptomatic or that can cause variable neurological manifestations such as seizures, non-specific headaches, progressive or transient focal neurologic deficits, and/or cerebral hemorrhages. […] To date, mutations in three genes have been demonstrated to cause familial CCM; KRIT1, CCM2 and PDCD10, located on chromosome 7q21.2, 7p13, and 3q26.1 respectively, which encode proteins that, among their various functions, modulate junction formation between vascular endothelial cells.
  • #21 Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management | European Journal of Human Genetics
    https://www.nature.com/articles/ejhg2011155
    Cerebral cavernous (or capillary-venous) malformations (CCM) have a prevalence of about 0.10.5% in the general population. Genes mutated in CCM encode proteins that modulate junction formation between vascular endothelial cells. Mutations lead to the development of abnormal vascular structures. […] At least three genes have been associated with CCM: k-rev interaction trapped protein 1 (KRIT1) (CCM1; OMIM no. 604214), MGC4607 (CCM2; OMIM no. 603284) and programmed cell death 10 (PDCD10) (CCM3; OMIM no. 603285). These genes encode proteins that are involved in junction formation between vascular endothelial cells. Mutations in the CCM genes, which are in general loss-of-function mutations, lead to the development of abnormal vascular structures characterized by thin-walled, dilated blood vessels with gaps between the endothelial cells.
  • #22
    https://www.omim.org/entry/116860
    A number sign (#) is used with this entry because of evidence that cerebral cavernous malformations-1 (CCM1) is caused by heterozygous germline mutation in the KRIT1 gene (604214) on chromosome 7q21. […] Evidence suggests that a 2-hit mechanism involving biallelic germline and somatic mutations is responsible for CCM1 pathogenesis; see PATHOGENESIS and MOLECULAR GENETICS sections. […] CCM2 (603284) is caused by germline mutation in the CCM2 gene (607929); CCM3 (603285) is caused by germline mutation in the PDCD10 gene (609118); and CCM4 (619538) is caused by somatic mutation in the PIK3CA gene (171834). […] Pagenstecher et al. (2009) suggested that complete lack of CCM protein in affected endothelial cells from CCM germline mutation carriers supports a 2-hit mechanism for CCM formation. […] Tang et al. (2017) concluded that their studies identified unexpected roles for the microbiome and innate immune signaling in the pathogenesis of a cerebrovascular disease, as well as strategies for its treatment.
  • #23 Genetics of Cavernous Malformation – Alliance to Cure Cavernous Malformation
    https://www.alliancetocure.org/home/cavernous-angioma-in-depth/genetics/genetics-of-cavernous-angioma/
    Familial cavernous malformations are caused by a genetic mutation found in every cell in your body, destroying the function of one copy of one of the CCM genes. Several studies suggest that lesion formation is seeded when a brain blood vessel cell acquires a second mutation in the other copy of that CCM gene, resulting in a complete loss of function in a brain blood vessel cell. This loss of function causes that cell to start growing and dividing uncontrollably (like a tumor) and starts the formation of a cavernous malformation lesion. […] Even though mutations are not inherited in sporadic cavernous malformation, the cause of sporadic lesion development is quite similar to familial lesions. Researchers have found that there are genetic mutations of the CCM genes, but that these mutations occur only in the blood vessels of the sporadic CCM lesion. These mutations are not heritable; they are randomly acquired within brain blood vessels and cause a CCM lesion to form.
  • #24 Cerebral Cavernous Malformations – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538144/
    Interactions occur between various CCM protein products as well as between these products and other cellular machinery responsible for a range of functions, including cell-cell communication and angiogenesis. The most critical dysfunction identified in CCM mutations is endothelial junction permeability, an effect mediated by Notch1 and Rho kinase activity. This correlates with the characteristic histopathological appearance of CCM, which lacks mature vessel wall architecture and a mature blood-brain barrier. CCMs are distinguished from other cerebral vascular malformations by the absence of direct arteriovenous communication and lack of intervening brain parenchyma. […] Recently, genetic studies on the surgically resected lesions from sporadic cases lacking inherited germline mutations have shown somatic mutations of the same 3 CCM genes. This could point towards identical molecular mechanisms in both familial and sporadic CCMs.
  • #25 Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management | European Journal of Human Genetics
    https://www.nature.com/articles/ejhg2011155
    On the basis of animal, as well as human studies, evidence grows for the two-hit mechanism. […] Finally, trans-heterozygosity, in which a patient has synergistic mutations in different genes of the CCM pathway (for example, a germline mutation in the KRIT1 gene with an additional somatic mutation in the MGC4607 or PDCD10 gene), might also explain intrafamilial clinical variability.
  • #26 Delving Into Cavernous Malformations – Pacific Neuroscience Institute
    https://www.pacificneuroscienceinstitute.org/blog/neurovascular-malformations/delving-into-cavernous-malformations/
    Cavernomas, also known as cavernous angiomas or cavernous malformations, are clusters of abnormal blood vessels typically found in the brain or spinal cord. The exact cause of cavernomas isn’t always clear, but several factors can trigger their formation or lead to their symptoms becoming apparent: […] Genetic Factors: Some people inherit a predisposition to develop cavernomas. Familial cavernous malformation, caused by mutations in specific genes (like CCM1, CCM2, or CCM3), can lead to multiple cavernomas. […] Developmental Factors: Cavernomas can develop sporadically without any family history. […] Radiation Therapy: In some cases, cavernomas can form as a side effect of radiation therapy, particularly in the brain. […] Trauma: Although rare, head trauma has been suggested as a potential trigger for the formation of cavernomas or the hemorrhage of an existing one.
  • #27 Cavernous Malformation – 20 Questions Answered
    https://www.alliancetocure.org/home/for-patients/newly-diagnosed/20-questions-answered-cavernous-malformation-angioma-cavernoma/
    Some people have more than one cavernous malformation (cavernous angioma, cavernoma). This can happen for several reasons: Most commonly, people with more than one cavernous malformation have a hereditary form of the illness. People with the genetic form of the illness typically develop additional cavernous malformations over time. […] Brain or spinal radiation for cancer treatment can cause cavernous malformations to form many years later. In people with the hereditary form, radiosurgery to treat a cavernous malformation may also cause more lesions to form. […] Sporadic cavernous malformation means that you are the only one in your family to have a cavernous malformation, and you do not have a genetic mutation that would cause your children to inherit the illness. […] We do not know what causes hemorrhage. Without evidence, it is hard for doctors to recommend specific precautions.
  • #28 Cavernoma Symptoms & Treatments | Pacific Stroke & Neurovascular Center
    https://www.pacificneuroscienceinstitute.org/stroke-neurovascular/conditions-and-treatments/brain-vascular-malformation/cavernoma/
    A cavernous malformation is also called a cavernoma or a cerebral cavernous malformation (CCM), but these names are all interchangeable and refer to the same diagnosis. […] Cavernomas are a vascular mass made up of abnormal dilated blood vessels characterized by distended blood-filled caverns. […] The majority of cavernomas that are diagnosed occur in individuals with only a single lesion and no family history of the disease (these cases are termed sporadic meaning they are not caused by an inherited genetic mutation). […] Individuals with the familial (genetic) form of cavernomas are likely to have multiple lesions and may be more likely to experience symptoms associated with the disorder. […] At least 40% of sporadic cavernomas may develop within the vicinity of a DVA. The significance of DVA association with sporadic lesions is currently under investigation; perhaps this observation may suggest a difference in developmental mechanisms between sporadic and familial cavernomas.
  • #29 Delving Into Cavernous Malformations – Pacific Neuroscience Institute
    https://www.pacificneuroscienceinstitute.org/blog/neurovascular-malformations/delving-into-cavernous-malformations/
    Hormonal Changes: Some studies suggest that hormonal changes, such as those occurring during pregnancy, can exacerbate symptoms or lead to the detection of a previously asymptomatic cavernoma. […] Aging: As people age, the risk of symptoms or hemorrhage from a cavernoma can increase, possibly due to the cumulative effects of small, undetected bleeding events over time.
  • #30 Cavernous Malformations | Boston Children’s Hospital
    https://www.childrenshospital.org/conditions/cavernous-malformations
    Cavernous malformations can occur anywhere in the body, but usually only cause serious problems in the brain and spinal cord. […] The exact cause of cavernous malformations is not well understood, though some types may be inherited. […] Head trauma may increase the risk for cavernous malformations to bleed, so doctors recommend that children with cavernous malformations avoid activities and sports with a high likelihood of head trauma, such as football.
  • #31 Familial multiple cavernous malformation syndrome | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/familial-multiple-cavernous-malformation-syndrome?lang=us
    The familial multiple cavernous malformation syndrome, or familial cerebral cavernous malformation syndrome, is uncommon, accounting for only a minority of cavernous malformations. […] The definition of familial multiple cavernous malformation syndrome is when there is one or more of the following: multiple cerebral cavernous malformations, five or more cavernomas, or one cavernoma and at least one other family member with one or more cavernomas. […] Mutations in one of the three genes, KRIT1, CCM2 or PDCD10, which are associated with this disease. […] Familial cases usually have an autosomal dominant pattern of inheritance with incomplete penetrance. […] In sporadic cases, up to one-third of cases of cavernous malformations will have multiple. When familial, the number of cavernomas is higher, typically five or more and may be innumerable.
  • #32 < ?php wp_title( '|', true, 'right' ); ?>
    https://surgicalneurologyint.com/surgicalint-articles/pediatric-cerebral-cavernous-malformations-genetics-pathogenesis-and-management/
    It has been shown that many cases thought to be sporadic do, in fact, harbor familial mutations. […] Three genetic loci have been associated with and account for ~80% of familial CCM: CCM1/Krit1, CCM2/MGC4607, and CCM3/PDCD10. […] A Knudsonian two-hit hypothesis has been presented to account for all cases of CCM. […] In the sporadic form of the disease, the Knudsonian two-hit hypothesis posits the acquisition of two somatic mutations in homologous genes, which has never been directly shown, and thus remains to be explained. […] CCMs may occur sporadically or be transmitted in an autosomal dominant fashion with variable penetrance; the familial type has been reported to account for roughly half of the cases in Hispanics and up to one-fifth of the cases in Caucasians, and is also associated with a greater annual risk of symptomatic bleeding.
  • #33 Cavernous Malformation – 20 Questions Answered
    https://www.alliancetocure.org/home/for-patients/newly-diagnosed/20-questions-answered-cavernous-malformation-angioma-cavernoma/
    Individuals with a mutation on the CCM3 gene may have additional features. About half of individuals with a mutation on the CCM3 gene have their first hemorrhage as children. They hemorrhage more often and develop new lesions more quickly, at a rate of 2-3 new lesions per year (compared to an average of one lesion every two years for those with CCM1 or CCM2 mutations).
  • #34 Cavernous malformations | MedLink Neurology
    https://www.medlink.com/articles/cavernous-malformations
    The presence of these compounds is felt to be indicative of enhanced angiogenic activity. […] A progressive process of thrombosis within cerebral venules associated capillary bleeding and hematoma expansion has been postulated as a potential pathophysiologic mechanism for the development of cavernous malformations. […] The lack of intervening brain parenchyma is one of the characteristic pathologic markers of cavernous malformations. […] The role of the venous system has been further explored as a possible factor in lesion development as well. […] The potential for a fourth locus has also been suggested. […] The risk factors for hemorrhage were female sex, prior hemorrhage, and perilesional edema.
  • #35 < ?php wp_title( '|', true, 'right' ); ?>
    https://surgicalneurologyint.com/surgicalint-articles/pediatric-cerebral-cavernous-malformations-genetics-pathogenesis-and-management/
    Furthermore, single nucleotide polymorphisms (SNPs) of inflammatory and immune response genes have been associated with different features of CCM natural history, including disease burden and severity of risk of intracerebral hemorrhage. […] This information may have implications for risk stratification and treatment planning.
  • #36 Cerebral cavernous venous malformation | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/cerebral-cavernous-venous-malformation?lang=us
    The majority of lesions remain asymptomatic throughout life and are found incidentally. Presentation due to hemorrhage may cause a headache, seizure or focal neurological deficit. The risk of hemorrhage is 1% per patient-year for familial cases, somewhat less for sporadic lesions, and very rare (0.1% per patient-year) for incidental lesions. […] Histologically cavernous malformations are composed of a „mulberry-like” cluster of hyalinized dilated thin-walled capillaries, with surrounding hemosiderin. These vessels are thrombosed to varying degrees. Unlike CNS capillary telangiectasia, there is no normal brain between the interstices of these lesions. […] On occasion, they are intimately associated with a developmental venous anomaly (DVA), in which case they are known as a mixed vascular malformation.